Budget Amount *help |
¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2014: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2013: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2012: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
|
Outline of Final Research Achievements |
We recognized that the activation of Ral induced by the down-regulation of RalGAPα2 had a possibility to be related to the bladder carcinogenesis, through suppressing Filamin A expression. We confirmed that the immunostaining intensity of Filamin A in human bladder cancer tissue was correlated with pathological aggressiveness and infiltration. Suppression of Filamin A led to reduced proliferation in bladder cancer cell lines, whereas we did not observe significant changes in cell migration and invasion. Filamin A did not affect the tumor growth and local invasion ability in subcutaneous and renal subcapsular xenograft models.
|